# Certolizumab pegol

## Cimzia inj 200mg/1mL

##### 臨採

| TAH Drug Code      | [ICIM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICIM)                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | No Data                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | SC, Ankylosing spondylitis, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis 400 mg once and then repeat at weeks 2 and 4; maintenance, 200 mg every 2 weeks or 400 mg once every 4 weeks. Crohn's disease 400 mg (as 2 injections of 200 mg) once and then repeat at weeks 2 and 4; maintenance , 400 mg once every 4 weeks. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | No Data                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | No Data                                                                                                                                                                                                                                                                                                                                                                            |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                      |

